Karacin, COksuzoglu, BDemirci, AKeskinkiliç, MBaytemür, NKYilmaz, FSelvi, OErdem, DAvsar, EPaksoy, NDemir, NGöksu, SSTürker, SBayram, EÇelebi, AYilmaz, HKuzu, ÖFKahraman, SGökmen, ISakin, AAlkan, ANayir, EUgrakli, MAcar, ÖErtürk, IDemir, HAslan, FSönmez, ÖKorkmaz, TCelayir, ÖMKaradag, IKayikçioglu, ESakalar, TÖktem, INEren, TErul, EMocan, EEKalkan, ZYildirim, NErgün, YAkagündüz, BKarakaya, SKut, ETeker, FDemirel, BÇKaraboyun, KAlmuradova, EÜnal, OÜOyman, AIsik, DOkutur, KÖztosun, BGülbagci, BBKalender, MESahin, ESeyyar, MÖzdemir, ÖSelçukbiricik, FKanitez, MDede, IGümüs, MGökmen, EYaren, AMenekse, SEbinç, SAksoy, SImamoglu, GIAltinbas, MÇetin, BUluç, BOEr, ÖKaradurmus, NErdogan, APArtaç, MTanriverdi, ÖÇiçin, ISendur, MANOktay, EBayoglu, IVPaydas, SAydiner, ASalim, DKGeredeli, ÇYavuzsen, TDogan, MHacibekiroglu, I2024-07-182024-07-181471-2407http://akademikarsiv.cbu.edu.tr:4000/handle/123456789/11040EnglishEfficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy (vol 23, 136, 2023)Correction